-

Fighting Cancer: Dr. Krishnan Suthanthiran’s 60-Year Journey

WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran, President and Founder of TeamBest Global (TBG) and the Best Cure Foundation, will exhibit at the 15th Annual Conference of the Indian Brachytherapy Society (IBSCON), August 29-31, 2025. His company, TeamBest Asia (a TBG company), will showcase Suthanthiran’s 60-year journey focusing on the prevention, early detection, and effective treatment of cancer.

Suthanthiran's 60-year journey focuses on combating the devastation cancer causes to patients and their families.

Share

Suthanthiran’s enterprises are pioneers and innovators of numerous technologies presently in use or planned for use. Currently, his organization manufactures X-ray blood irradiators in India and intends to ship them to customers by the end of this year.

Suthanthiran's father, diagnosed with colon cancer in 1965, suffered for three years while cancer spread throughout his entire body before eventually passing in 1968. This tragic event helped to shape Suthanthiran's primary career goal: to dedicate his life to medicine, specifically cancer research and treatment. His 60-year journey focuses on combating the devastation cancer causes to patients and their families. As part of this mission, TeamBest Asia and TeamBest Global will put in place manufacturing facilities to produce all equipment needed to establish over 1,000 nonprofit Best Cure Pro Health Centers for proactive, preventive, primary, medical, dental, and eyecare wellness centers, and Best Cure nonprofit medical centers, including cancer centers, the first of these will be established in India in the first quarter of 2026.

Suthanthiran also intends to document his life in a future film titled "Cancer: A 60-Year Journey."

For more information about TeamBest Asia and their products, please visit http://www.teambest.in.

For more information about robotic flash therapy systems, please visit http://www.teambest.com/news/CERN_SeptOct2025_TBG_FRT_BCS.pdf.

“HDRs Then and Now” graphic: http://graphics.teambest.com/HDR_ThenAndNow.jpg.

For more information about Best Cure Pro Health and Best Cure Medical Centers, please visit http://www.teambest.com/press/EINPresswire-729534915-bcf-bref-tbg-companies-seek-global-financial-support-to-establish-1000s-of-best-cure-pro-health-medical-centers.pdf.

For more information about Krishnan Suthanthiran, please visit his bio page at http://www.teambest.com/about_bio.html.

Contacts

Krishnan Suthanthiran, +1 571-437-9802
krish@teambest.com

Industry:

TeamBest Global

Release Versions
English

Contacts

Krishnan Suthanthiran, +1 571-437-9802
krish@teambest.com

More News From TeamBest Global

Global Non-Resident Indians Association Aims to Promote India as a Global Leader

WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran, President and Founder of TeamBest Global (TBG), announces the establishment of the Global Non-Resident Indians Association (GNRIA) as a division of Global Best Cure Foundation, a nonprofit organization established in India. Suthanthiran left India in 1969 and has lived in the U.S. for the past 53 years. As an Indo-American, he is proud to cherish his Indian heritage and American citizenship and to be an Indo-American. Many non-resident Ind...

To Leaders of Canadian First Nations and Federal/Provincial Governments—Fueling the Future with Kitsault Energy

WASHINGTON--(BUSINESS WIRE)--In 2013, Dr. Suthanthiran, President/Founder of TeamBest Global Companies, announced his dedicated energy pipeline corridor/export port/terminal to carry all of Canada’s energy products to Kitsault, BC, Canada, a town owned by Suthanthiran, northwest of Prince Rupert, BC. Suthanthiran, a healthcare professional, has devoted over fifty years to cheering, helping, and saving lives daily. The dedicated pipeline corridor is now a reality, w/multiple pipelines approved a...

Best Vascular/Novoste Celebrates 24th Anniversary of Vascular Brachytherapy Approval & Use of by US FDA

WASHINGTON--(BUSINESS WIRE)--It’s been over 30 years since the first vascular brachytherapy (VBT) animal experiments and human clinical trials were performed and 24 years since the approval of VBT for human clinical use for the treatment of in-stent coronary artery restenosis by the US FDA on November 3, 2000. Dr. Paul Teirstein, at Scripps Clinic in La Jolla, California, in collaboration with Virginia-based Best Medical International (BMI), began the first randomized, double-blind human clinic...
Back to Newsroom